Registry of Febrile Neutropenia and Invasive Fungal Infections
NCT01684189 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-09-12
Summary
Objectives:
1. To assess the percentage of febrile neutropenia and suspected fungal-related febrile episodes in patients receiving chemotherapy
2. To explore the percentage/distribution of infectious origins of febrile neutropenia
3. To explore the percentage/distribution of infectious pathogens of febrile neutropenia
4. To explore clinical outcomes of different infectious origins/pathogens in febrile neutropenia episodes
5. To have a clear view of therapeutic actions in the management of hematological patients with febrile neutropenia and suspected fungal-related febrile episodes
Conditions
- Hematological Disease
- Febrile Neutropenia
- Fungal Infections
Interventions
- OTHER
-
Patient registry
Patient registry without study intervention
Sponsors & Collaborators
-
Chang Gung Memorial Hospital
lead OTHER
Principal Investigators
-
Ming-Chung Wang, M.D. · Chang Gung Memorial Hospital
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Completion
- 2013-08-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia
NCT00190463 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of Empirical Anti-Infective Therapy in Neutropenic Febrile Patients.
NCT07204522 ·Status: RECRUITING
-
Short-term Antibiotic Treatment for Unexplained Fever in Solid Cancer Patients With Febrile Neutropenia
NCT01450241 ·Status: WITHDRAWN ·Phase: NA
-
Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
NCT04081753 ·Status: COMPLETED ·Phase: NA
-
Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma
NCT00932217 ·Status: UNKNOWN ·Phase: PHASE3
-
Prophylactic Use of PEG-rhG-CSF in Medium-high Risk of FN in Chemotherapy of Breast Cancer
NCT03618810 ·Status: UNKNOWN
-
The Oral Cavity as a Source of Febrile Neutropenia
NCT02702583 ·Status: COMPLETED
-
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
NCT03793205 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis
NCT03701841 ·Status: UNKNOWN
-
Antimicrobial Revision in Persistent Febrile Neutropenia
NCT05784844 ·Status: WITHDRAWN ·Phase: PHASE4
-
Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia
NCT02856204 ·Status: COMPLETED
-
Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients
NCT03530072 ·Status: COMPLETED
-
Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy
NCT03434795 ·Status: COMPLETED
-
Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia
NCT01918241 ·Status: UNKNOWN ·Phase: PHASE2
-
Fever and Neutropenia in Pediatric Oncology Patients
NCT03768869 ·Status: WITHDRAWN ·Phase: PHASE3
-
Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
NCT02178475 ·Status: COMPLETED
-
Analysis of the Risk Factors for the Neutropenic Fever in the High Risk NHL Patients for Developing Febrile Neutropenia Who Received 3-weekly CHOP-like Chemotherapy With Primary G-CSF Prophylaxis; Prospective Multicenter Observation Study
NCT01763398 ·Status: COMPLETED
-
AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients
NCT05793073 ·Status: COMPLETED
-
A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Solid Tumors
NCT03798665 ·Status: UNKNOWN
-
A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies
NCT06254742 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving Chemotherapy
NCT01560195 ·Status: UNKNOWN ·Phase: PHASE3
-
Telpegfilgrastim Injection to Reduce the Risk of Neutropenia in Patients With Solid Tumor
NCT07096479 ·Status: RECRUITING
-
The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia
NCT02761460 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias
NCT01144793 ·Status: COMPLETED
-
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
NCT04101760 ·Status: UNKNOWN ·Phase: PHASE3